Skip to main content

Advertisement

SpringerLink
Log in

Combined surgical resection and radiofrequency ablation as treatment for metastatic ocular melanoma

  • Original Article
  • Published:
Surgery Today Aims and scope Submit manuscript

Abstract

Purpose

Ocular melanoma is a rare disease with a strong predilection for the liver. Systemic and locoregional treatments for metastatic ocular melanoma have had disappointing results, with an average survival of 5–7 months. Resection and/or radiofrequency ablation (RFA) of liver lesions were attempted to improve the patient outcomes.

Methods

Eight patients with liver metastasis from ocular melanoma underwent surgery and/or RFA at the University of Southern California, University Hospital from 1 January 2001 to 31 December 2009. Their charts were retrospectively reviewed.

Results

All patients had undergone eye enucleation as the primary treatment. Four patients had all metastatic liver lesions addressed: one patient underwent left lateral segmentectomy and three patients had combinations of left lateral segmentectomies, wedge resections and RFA of two to four lesions. Two patients underwent surgical biopsies for diagnosis, one patient was unresectable and one patient underwent RFA of a dominant lesion. The median survival was 36 months. The median survival of patients who underwent surgery alone or in conjunction with RFA to address all liver lesions was 46 months.

Conclusions

There are few reports of RFA for metastatic ocular melanoma. RFA of liver lesions in addition to resection can perhaps lead to improved survival and may play a critical role in the future management of this disease.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Papachristou DN, Fortner JJ. Surgical treatment of metastatic melanoma confined to the liver. Int Surg. 1983;68:145–8.

    PubMed  CAS  Google Scholar 

  2. Sato T. Locoregional management of hepatic metastasis from primary uveal melanoma. Semin Oncol. 2010;37:127–38.

    Article  PubMed  Google Scholar 

  3. Rose DM, Essner R, Hughes TM, et al. Surgical resection for metastatic melanoma to the liver: the John Wayne Cancer Institute and Sydney Melanoma Unit experience. Arch Surg. 2001;136:950–5.

    Article  PubMed  CAS  Google Scholar 

  4. Bedikian AY, Legha SS, Mavligit G, et al. Treatment of uveal melanoma metastatic to the liver: a review of the M. D. Anderson Cancer Center experience and prognostic factors. Cancer. 1995;76:1665–70.

    Article  PubMed  CAS  Google Scholar 

  5. Pawlik TM, Zorzi D, Abdalla EK, et al. Hepatic resection for metastatic melanoma: distinct patterns of recurrence and prognosis for ocular versus cutaneous disease. Ann Surg Oncol. 2006;13:712–20.

    Article  PubMed  Google Scholar 

  6. Feldman ED, Pingpank JF, Alexander HR Jr. Regional treatment options for patients with ocular melanoma metastatic to the liver. Ann Surg Oncol. 2004;11:290–7.

    Article  PubMed  Google Scholar 

  7. Yamamoto A, Chervoneva I, Sullivan KL, et al. High-dose immunoembolization: survival benefit in patients with hepatic metastases from uveal melanoma. Radiology. 2009;252:290–8.

    Article  PubMed  Google Scholar 

  8. Sato T, Eschelman DJ, Gonsalves CF, et al. Immunoembolization of malignant liver tumors, including uveal melanoma, using granulocyte-macrophage colony-stimulating factor. J Clin Oncol. 2008;26:5436–42.

    Article  PubMed  CAS  Google Scholar 

  9. Hafstrom LR, Holmberg SB, Naredi PL, et al. Isolated hyperthermic liver perfusion with chemotherapy for liver malignancy. Surg Oncol. 1994;3:103–8.

    Article  PubMed  CAS  Google Scholar 

  10. Hildebrand P, Kleemann M, Roblick U, Mirow L, Birth M, Bruch HP. Laparoscopic radiofrequency ablation of unresectable hepatic malignancies: indication, limitation and results. Hepatogastroenterology. 2007;54:2069–72.

    PubMed  Google Scholar 

  11. Robertson DJ, Stukel TA, Gottlieb DJ, Sutherland JM, Fisher ES. Survival after hepatic resection of colorectal cancer metastases: a national experience. Cancer. 2009;115:752–9.

    Article  PubMed  Google Scholar 

  12. Weitz J, Blumgart LH, Fong Y, et al. Partial hepatectomy for metastases from noncolorectal, nonneuroendocrine carcinoma. Ann Surg. 2005;241:269–76.

    Article  PubMed  Google Scholar 

  13. Minami Y, Kudo M. Radiofrequency ablation of hepatocellular carcinoma: current status. World J Radiol. 2010;2:417–24.

    Article  PubMed  Google Scholar 

  14. Bleicher RJ, Allegra DP, Nora DT, Wood TF, Foshag LJ, Bilchik AJ. Radiofrequency ablation in 447 complex unresectable liver tumors: lessons learned. Ann Surg Oncol. 2003;10:52–8.

    Article  PubMed  Google Scholar 

  15. Amersi FF, McElrath-Garza A, Ahmad A, et al. Long-term survival after radiofrequency ablation of complex unresectable liver tumors. Arch Surg 2006;141:581–7 (discussion 7–8).

    Google Scholar 

  16. Salmon RJ, Levy C, Plancher C, et al. Treatment of liver metastases from uveal melanoma by combined surgery-chemotherapy. Eur J Surg Oncol. 1998;24:127–30.

    Article  PubMed  CAS  Google Scholar 

  17. Hsueh EC, Essner R, Foshag LJ, Ye X, Wang HJ, Morton DL. Prolonged survival after complete resection of metastases from intraocular melanoma. Cancer. 2004;100:122–9.

    Article  PubMed  Google Scholar 

  18. Aoyama T, Mastrangelo MJ, Berd D, et al. Protracted survival after resection of metastatic uveal melanoma. Cancer. 2000;89:1561–8.

    Article  PubMed  CAS  Google Scholar 

  19. Rivoire M, Kodjikian L, Baldo S, Kaemmerlen P, Negrier S, Grange JD. Treatment of liver metastases from uveal melanoma. Ann Surg Oncol. 2005;12:422–8.

    Article  PubMed  Google Scholar 

  20. Fournier GA, Albert DM, Arrigg CA, Cohen AM, Lamping KA, Seddon JM. Resection of solitary metastasis. Approach to palliative treatment of hepatic involvement with choroidal melanoma. Arch Ophthalmol. 1984;102:80–2.

    Article  PubMed  CAS  Google Scholar 

  21. Gunduz K, Shields JA, Shields CL, Sato T, Mastrangelo MJ. Surgical removal of solitary hepatic metastasis from choroidal melanoma. Am J Ophthalmol. 1998;125:407–9.

    Article  PubMed  CAS  Google Scholar 

  22. Mariani P, Piperno-Neumann S, Servois V, et al. Surgical management of liver metastases from uveal melanoma: 16 years’ experience at the Institut Curie. Eur J Surg Oncol. 2009;35:1192–7.

    Article  PubMed  CAS  Google Scholar 

  23. Frenkel S, Nir I, Hendler K, et al. Long-term survival of uveal melanoma patients after surgery for liver metastases. Br J Ophthalmol. 2009;93:1042–6.

    Article  PubMed  CAS  Google Scholar 

  24. Curley SA, Izzo F, Delrio P, et al. Radiofrequency ablation of unresectable primary and metastatic hepatic malignancies: results in 123 patients. Ann Surg. 1999;230:1–8.

    Article  PubMed  CAS  Google Scholar 

  25. Lin SM. Recent advances in radiofrequency ablation in the treatment of hepatocellular carcinoma and metastatic liver cancers. Chang Gung Med J. 2009;32:22–32.

    PubMed  Google Scholar 

  26. Wang YH, Liu JF, Li F, et al. Radiofrequency ablation combined with transarterial chemoembolization for unresectable primary liver cancer. Chin Med J (Engl). 2009;122:889–94.

    Google Scholar 

  27. Chen MS, Li JQ, Zheng Y, et al. A prospective randomized trial comparing percutaneous local ablative therapy and partial hepatectomy for small hepatocellular carcinoma. Ann Surg. 2006;243:321–8.

    Article  PubMed  Google Scholar 

  28. Berber E, Tsinberg M, Tellioglu G, Simpfendorfer CH, Siperstein AE. Resection versus laparoscopic radiofrequency thermal ablation of solitary colorectal liver metastasis. J Gastrointest Surg. 2008;12:1967–72.

    Article  PubMed  Google Scholar 

  29. Zhou Y, Zhao Y, Li B, et al. Meta-analysis of radiofrequency ablation versus hepatic resection for small hepatocellular carcinoma. BMC Gastroenterol. 2010;10:78.

    Article  PubMed  Google Scholar 

  30. Rhim H, Lim HK. Radiofrequency ablation of hepatocellular carcinoma: pros and cons. Gut Liver. 2010;4(Suppl 1):S113–8.

    Article  PubMed  Google Scholar 

  31. Gravante G, Overton J, Sorge R, et al. Radiofrequency ablation versus resection for liver tumours: an evidence-based approach to retrospective comparative studies. J Gastrointest Surg. 2011;15:378–87.

    Article  PubMed  Google Scholar 

  32. Crocetti L, de Baere T, Lencioni R. Quality improvement guidelines for radiofrequency ablation of liver tumours. Cardiovasc Intervent Radiol. 2010;33:11–7.

    Article  PubMed  Google Scholar 

  33. Krishnamurthy VN CJ, Latorre L. Radiofrequency Ablation of Hepatic Lesions: A Review. Applied Radiology 2003;32.

  34. Choi D, Lim HK, Rhim H. Concurrent and subsequent radiofrequency ablation combined with hepatectomy for hepatocellular carcinomas. World J Gastrointest Surg. 2010;2:137–42.

    Article  PubMed  Google Scholar 

  35. Kornprat P, Jarnagin WR, DeMatteo RP, Fong Y, Blumgart LH, D’Angelica M. Role of intraoperative thermoablation combined with resection in the treatment of hepatic metastasis from colorectal cancer. Arch Surg. 2007;142:1087–92.

    Article  PubMed  Google Scholar 

  36. Berber E, Ari E, Herceg N, Siperstein A. Laparoscopic radiofrequency thermal ablation for unusual hepatic tumors: operative indications and outcomes. Surg Endosc. 2005;19:1613–7.

    Article  PubMed  CAS  Google Scholar 

Download references

Conflict of interest

Elika Derek and other co-authors have no conflicts of interest to declare.

Author information

Authors and Affiliations

  1. Division of Hepatobiliary/Pancreatic Surgery and Abdominal Transplantation, Keck School of Medicine, University of Southern California, 1500 San Pablo, Suite 400, Los Angeles, CA, 90033, USA

    Elika Derek, Lea Matsuoka, Sophoclis Alexopoulos, Yuri Genyk & Rick Selby

  2. Department of Pathology, Keck School of Medicine, University of Southern California, Los Angeles, USA

    Alexander Fedenko

Authors
  1. Elika Derek
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Lea Matsuoka
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Sophoclis Alexopoulos
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Alexander Fedenko
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Yuri Genyk
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Rick Selby
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Lea Matsuoka.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Derek, E., Matsuoka, L., Alexopoulos, S. et al. Combined surgical resection and radiofrequency ablation as treatment for metastatic ocular melanoma. Surg Today 43, 367–371 (2013). https://doi.org/10.1007/s00595-012-0244-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00595-012-0244-3

Keywords

Search

Navigation